Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Coca-Cola Co K (KO) vs GeneDx Holdings Corp (WGS) Price & Performance

The Coca-Cola Co KTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

The Coca-Cola Co K vs GeneDx Holdings Corp — how do they compare? The Coca-Cola Co K trades at $85.69 (market cap $372.08B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: The Coca-Cola Co K is far larger — about 152.5× GeneDx Holdings Corp's market cap, and The Coca-Cola Co K pays a 2.45% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

KOWGS
Market Cap
$372.08B$2.44B
Volume
14,630,257
Sector
Consumer StaplesTechnology
52-Week High
$89.08$167.51
52-Week Low
$65.67$34.51
Enterprise Value
$399.26B$2.48B
Dividend Yield
2.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Coca-Cola Co K

Coca-Cola (KO) trades at $86.87, down 0.21% today, with a bullish technical signal supported by moving averages and RSI near 69. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding expectations, and maintains robust profitability with a 28.56% net margin. Recent news highlights institutional buying and stable demand trends ahead of Q3 earnings.

KO offers a solid dividend history with 64 consecutive years of increases, but faces risks from regional demand divergence and high debt. Analysts are bullish with a $95.83 price target, implying 10% upside, though valuation multiples like P/E of 25.97 suggest premium pricing relative to peers.

GeneDx Holdings Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About The Coca-Cola Co K

The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.

Read more on KO

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS